- Home
- AQMS vs PASG Comparison
AQMS vs PASG Comparison
Compare AQMS & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQMS
- PASG
- Stock Information
- Founded
- AQMS 2014
- PASG 2017
- Country
- AQMS United States
- PASG United States
- Employees
- AQMS N/A
- PASG N/A
- Industry
- AQMS Metal Fabrications
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- AQMS Industrials
- PASG Health Care
- Exchange
- AQMS Nasdaq
- PASG Nasdaq
- Market Cap
- AQMS 24.2M
- PASG 27.6M
- IPO Year
- AQMS 2015
- PASG 2020
- Fundamental
- Price
- AQMS $7.40
- PASG $6.25
- Analyst Decision
- AQMS Buy
- PASG Strong Buy
- Analyst Count
- AQMS 1
- PASG 4
- Target Price
- AQMS $12.00
- PASG $59.25
- AVG Volume (30 Days)
- AQMS 4.3M
- PASG 36.3K
- Earning Date
- AQMS 11-12-2025
- PASG 11-10-2025
- Dividend Yield
- AQMS N/A
- PASG N/A
- EPS Growth
- AQMS N/A
- PASG N/A
- EPS
- AQMS N/A
- PASG N/A
- Revenue
- AQMS N/A
- PASG N/A
- Revenue This Year
- AQMS N/A
- PASG N/A
- Revenue Next Year
- AQMS $550.00
- PASG N/A
- P/E Ratio
- AQMS N/A
- PASG N/A
- Revenue Growth
- AQMS N/A
- PASG N/A
- 52 Week Low
- AQMS $3.37
- PASG $5.12
- 52 Week High
- AQMS $39.40
- PASG $26.60
- Technical
- Relative Strength Index (RSI)
- AQMS 46.54
- PASG 33.73
- Support Level
- AQMS $6.54
- PASG $6.56
- Resistance Level
- AQMS $11.48
- PASG $7.91
- Average True Range (ATR)
- AQMS 1.50
- PASG 0.57
- MACD
- AQMS -0.60
- PASG -0.19
- Stochastic Oscillator
- AQMS 7.01
- PASG 6.71
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.